君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

未开盘 02-25 16:08:35

21.260

+0.240

+1.14%

最高21.440	最低21.060	成交量74.56万
今开21.340	昨收21.020	日振幅1.81%
总市值218.34亿	流通市值55.28亿	总股本10.27亿
成交额1,584万	换手率0.29%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":21.26,"timestamp":1772006915004,"preClose":21.02,"halted":0,"volume":745600,"delay":0,"changeRate":0.011417697431018173,"floatShares":260000000,"shares":1027000000,"eps":-1.3,"marketStatus":"未开盘","change":0.24,"latestTime":"02-25 16:08:35","open":21.34,"high":21.44,"low":21.06,"amount":15842158,"amplitude":0.018078,"askPrice":21.26,"askSize":3200,"bidPrice":21.1,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-1.048055,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":0,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":21.02,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"volumeRatio":0.786295,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":34.75,"timestamp":1772002800000,"preClose":34.27,"halted":0,"volume":6974200,"delay":0,"premium":"-46.38"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2614033113","title":"君实生物（688180）披露截至2026年1月31日证券变动月报表，2月25日股价上涨1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614033113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614033113?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:25","pubTimestamp":1772029518,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘，君实生物报收于34.75元，较前一交易日上涨1.4%，最新总市值为356.77亿元。近日，君实生物发布H股公告，披露截至2026年1月31日的证券变动月报表。公告显示，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于港交所上市，A股于上交所科创板上市。股份期权计划方面，H股及A股股票期权激励计划已于2025年9月29日获股东大会批准，本月无新增行权或股份变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500038130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","01877","161027","BK0239","688180","BK1515","BK1161"],"gpt_icon":0},{"id":"1191927142","title":"君实生物（01877）2026年1月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1191927142","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191927142?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:01","pubTimestamp":1772013717,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司于2026年2月25日发布2026年1月股份变动月报，报告期为2026年1月1日至1月31日。公司H股股票代码为01877，A股股票代码为688180。截至2026年1月31日，公司注册股本合计人民币1,026,689,871元，其中包括260,295,700股H股与766,394,171股A股。对比上月，两类股份已发行及注册股本均未出现变化。公司另有13,210,000份H股期权与24,700,000份A股期权处于有效期内，本月未出现行使或增减变动。截至本月末，整体股本结构维持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"gpt_icon":0},{"id":"2614777227","title":"港股异动 | 德琪医药-B(06996)涨超6% 与君实生物达成临床合作 推进ATG-037与JS207的联合探索","url":"https://stock-news.laohu8.com/highlight/detail?id=2614777227","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614777227?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:16","pubTimestamp":1772000181,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B涨超6%，截至发稿，涨6.4%，报3.66港元，成交额1332.6万港元。消息面上，德琪医药今早宣布，公司已与君实生物达成临床合作协议，双方将共同探索德琪医药的ATG-037与君实生物的JS207在中国大陆肿瘤患者中的联合治疗协同潜力。公司指，在免疫检查点抑制剂耐药已成为临床巨大挑战的背景下，ATG-037在I期试验中同CPI联用已展现出了强劲的逆转耐药能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688180","BK1515","BK4588","VT","BK1583","BK1191","BK1574","BK4585","VXUS","BK0239","BK1161","06996","01877"],"gpt_icon":0},{"id":"2614773959","title":"君实生物与德琪医药达成战略合作，共同开展JS207（PD-1/VEGF双抗）与ATG-037（CD73口服小分子抑制剂）联合用药研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2614773959","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614773959?lang=zh_cn&edition=full","pubTime":"2026-02-25 08:30","pubTimestamp":1771979400,"startTime":"0","endTime":"0","summary":"上海2026年2月25日 /美通社/ -- 北京时间2026年2月25日，君实生物宣布与德琪医药达成战略合作，双方将共同探索君实生物自主研发的JS207与德琪医药的ATG-037在中国大陆肿瘤患者中的联合治疗协同潜力。本次合作的科学依据在于CD73抑制与PD-1/VEGF双靶向机制之间的互补性及潜在协同作用。综合上述因素，将CD73阻断与PD-1/VEGF靶向策略联合应用，有望增强并维持治疗效果。JS207可同时以高亲和力结合于PD-1与VEGFA，有效阻断PD-1与PD-L1和PD-L2的结合，并抑制VEGF与其受体的结合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4888412_ZH88412_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1191","BK1583","BK1574","01877","PD","BK1515","BK0239","06996","688180","LU1169590202.USD","LU1169589451.USD","BK4023","BK1161"],"gpt_icon":0},{"id":"2614747108","title":"节后A股首个交易日 年轻人的“药理财”表现如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747108","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614747108?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:38","pubTimestamp":1771936713,"startTime":"0","endTime":"0","summary":"2月24日，A股节后首个交易日，医药商业板块和医疗器械板块领涨，分别上涨1.28%和0.66%，化学制药上涨0.50%，拉长时间线看，创新药、CXO、高端医疗器械等板块正加速复苏。这一表现，也将创下公司上市以来归母净利润的历史新高。昔日“疫苗之王”智飞生物，自上市以来首次年报亏损。目前，智飞生物的代理产品收入占比高达90%，其代理的默沙东HPV疫苗业务缩水，是其业绩下滑的关键因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1583","LU2125910500.SGD","LU0320764599.SGD","BK1141","06978","01877","LU2045819591.USD","BK1574","BK1576","03347","LU0708995583.HKD","BK1161","02315","09969","02359","09995","LU2242644610.SGD","LU0052750758.USD","LU1046422090.SGD"],"gpt_icon":0},{"id":"2613970761","title":"每日卖空追踪 | 君实生物 02月23日卖空量成交2.7万股，卖空比例为3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613970761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613970761?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835425,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月23日，跌0.18%，卖空量成交2.7万股，较上一交易日减少56.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163303a71563f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163303a71563f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1583","01877"],"gpt_icon":0},{"id":"2613611337","title":"君实生物02月23日主力净流出639.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613611337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613611337?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834556,"startTime":"0","endTime":"0","summary":"02月23日, 君实生物股价跌0.18%，报收21.84元，成交金额1555.4万元，换手率0.27%，振幅2.65%，量比0.57。君实生物今日主力资金净流出639.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨1.49%，主力资金累计净流出639.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入70.0万元，其中净流入天数为9日。该股主力净额占比0.11%，港股市场排名2699/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162027a4be7441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162027a4be7441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1161","BK1583","BK1515"],"gpt_icon":0},{"id":"2613427508","title":"Coherus押注“癌症联合治疗”：能真正延长患者生命吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2613427508","media":"Minhua笔记","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613427508?lang=zh_cn&edition=full","pubTime":"2026-02-22 23:38","pubTimestamp":1771774702,"startTime":"0","endTime":"0","summary":"过去十年，PD1 免疫检查点抑制剂的出现改变了肿瘤治疗格局，默沙东的 Keytruda更是成长为数百亿美元级的重磅产品。但 Keytruda 单药仅对 20%–30% 的患者有效，仍有大量患者需要更好的方案。Coherus Oncology CEO Denny Lanfear 指出，这正推动行业从单一药物转向多靶点、多机制的联合治疗，能同时攻击肿瘤的多个方面，或增强 PD1 药物的免疫效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260222234123a4bc7d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260222234123a4bc7d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1515","BK1583","BK1161"],"gpt_icon":0},{"id":"2612252506","title":"IO2.0争夺战打响，下一代肿瘤“药王”花落谁家？","url":"https://stock-news.laohu8.com/highlight/detail?id=2612252506","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612252506?lang=zh_cn&edition=full","pubTime":"2026-02-20 15:00","pubTimestamp":1771570819,"startTime":"0","endTime":"0","summary":"下一代肿瘤“药王”争夺战打响！撰文丨粽哥2025下一代肿瘤“药王”，极有可能诞生于PD-1+X领域。以K药为代表的PD-1单抗，开启了一代IO治疗时代，但却存在耐药和冷肿瘤缺乏应答的问题。临床上，T细胞耗竭现象是导致免疫检查点获得性耐药的关键机制。TIGIT是经典免疫逃逸靶点，在多种淋巴细胞上表达，被认为是“下一个PD-1”。不过，PD-1/TIGIT双抗或有望打破TIGIT“难以成药”的魔咒。TIGIT和PD-1表达之间存在很强的相关性，特别是在肺癌的肿瘤浸","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU2476274720.SGD","09887","LU0348767384.USD","01877","LU0348766576.USD","02898","02616","01530","LU0348783233.USD","LU0561508036.HKD","LU2399975544.HKD","LU0417516902.SGD","LU2488822045.USD","LU1961090484.USD","09995","LU2778985437.USD","01801","LU0348827113.USD","LU0417516571.SGD","LU0540923850.HKD","LU1720050803.USD","09926","LU0634319403.HKD","IE00B5MMRT66.SGD","BK1161","LU0417516738.SGD","LU0348784397.USD","02696","LU2476274308.USD","LU1794554557.SGD","LU0348825331.USD","IE00BPRC5H50.USD","BK1574","LU0348735423.USD","01177"],"gpt_icon":1},{"id":"2612348200","title":"每日卖空追踪 | 君实生物 02月16日卖空量成交1.9万股，卖空比例为11.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612348200","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612348200?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230622,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月16日，跌2.15%，卖空量成交1.9万股，较上一交易日减少73.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163251a700de9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163251a700de9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","BK1161","01877"],"gpt_icon":0},{"id":"2611825118","title":"君实生物等在河北成立医药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2611825118","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611825118?lang=zh_cn&edition=full","pubTime":"2026-02-14 11:52","pubTimestamp":1771041155,"startTime":"0","endTime":"0","summary":"人民财讯2月14日电，企查查APP显示，近日，君华（河北）医药有限公司成立，法定代表人为童景，注册资本为2000万元，经营范围包含：生物基材料制造；生物化工产品技术研发；药品生产；药品批发；药品委托生产等。企查查股权穿透显示，该公司由君实生物旗下上海君拓生物医药科技有限公司等共同持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602143650964879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01877","688180","BK0239","BK1515","BK1583","BK1161"],"gpt_icon":0},{"id":"2611634976","title":"每日卖空追踪 | 君实生物 02月12日卖空量成交3.64万股，卖空比例为2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611634976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611634976?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885026,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月12日，跌2.23%，卖空量成交3.64万股，较上一交易日减少58.06%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163315a6f28b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163315a6f28b4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1583","BK1515","BK1161"],"gpt_icon":0},{"id":"2610982090","title":"君实生物跌1.93% 2020年上市2募资共86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610982090","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610982090?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:49","pubTimestamp":1770799778,"startTime":"0","endTime":"0","summary":"中国经济网北京2月11日讯 君实生物 今日收报35.03元，跌幅1.93%。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票募集资金总额为48.36亿元，扣除发行费用后，募集资金净额为44.97亿元，较原计划多17.97亿元。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金合计86.12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260211/32012393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688180","BK1515","BK1583","BK1161","01877","BK0239"],"gpt_icon":0},{"id":"2610633641","title":"君实生物(01877)获董事长熊俊累计增持10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633641","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610633641?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:25","pubTimestamp":1770722741,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)公布控股股东、实际控制人之一兼董事长增持股份进展，截至本公告披露日，熊俊先生通过上海证券交易所系统以集中竞价方式累计增持公司 A 股股份10万股，约占公司总股本的 0.01%，累计成交总额为人民币 383.84 万元。本次增持计划尚未实施完毕，熊俊先生将继续按照相关增持计划，在增持计划实施期间内择机增持公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688180","BK1161","BK1583","BK0239","BK1515","01877"],"gpt_icon":0},{"id":"1178068811","title":"君实生物董事长增持10万股A股，累计斥资380万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178068811","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178068811?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:19","pubTimestamp":1770722354,"startTime":"0","endTime":"0","summary":"截至2月10日，君实生物董事长通过二级市场增持公司A股股份10万股，合计交易金额达380万元人民币。此次增持体现了公司管理层对未来发展前景的信心，并向市场传递积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0239","688180","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹，广生堂涨超10%，此前万邦德涨停，尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出，经历短期波动消化后，创新药板块已显现企稳回暖迹象。整体上，国金证券认为创新药前期回调较为充分，向上产业趋势明确，催化近期密集，继续看好板块投资机会。从未来增长潜力来看，多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","02196","00013","01548","BK1161","02096","01276","01877","BK1574","06978","02269","01177","01093","02228","03692","BK1583","01952","01513","BK1515","00512","06185","06160","01801"],"gpt_icon":0},{"id":"2610694858","title":"君实生物盘中异动 早盘急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610694858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610694858?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:49","pubTimestamp":1770691753,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘10时49分，君实生物股票出现异动，股价大幅拉升5.14%。截至发稿，该股报22.900港元/股，成交量175.78万股，换手率0.68%，振幅6.43%。君实生物股票所在的生物技术行业中，整体涨幅为2.96%。其相关个股中，荣昌生物、宜明昂科-B、歌礼制药-B涨幅较大，振幅较大的相关个股有帝王国际投资、百奥赛图-B、泰格医药，振幅分别为10.91%、8.24%、8.09%。药品批发,药品委托生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602101049139540851a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602101049139540851a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01877","BK1583"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17%  医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。2026年，继续看好中国创新药出海的产业趋势，继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会，期待JPM大会、ASCO等带来数据更新和BD催化。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06978","BK1587","LU0417516738.SGD","159506","01801","09939","LU0196878994.USD","LU2476274308.USD","LU0823426308.USD","02269","LU0417516902.SGD","LU2039709279.SGD","09969","LU0634319403.HKD","LU1969619763.USD","LU0051755006.USD","LU2488822045.USD","LU0856984785.SGD","LU2045819591.USD","LU1961090484.USD","09926","LU1688375341.USD","LU1046422090.SGD","02359","159992","LU0516423174.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU0572944931.SGD","159938","02162","09688","01877","LU0359202008.SGD","LU0502904849.HKD","02268","LU2476274720.SGD","01548","06990","LU0181495838.USD","02696","03347","LU0043850808.USD","LU0516422366.SGD","LU1720050803.USD","HK0000306701.USD","LU2242644610.SGD","09995","LU0348825331.USD"],"gpt_icon":1},{"id":"2610694852","title":"每日卖空追踪 | 君实生物 02月09日卖空量成交4.38万股，卖空比例为1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610694852","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610694852?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625825,"startTime":"0","endTime":"0","summary":"君实生物北京时间02月09日，涨4.71%，卖空量成交4.38万股，较上一交易日减少72.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163656a6e54eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163656a6e54eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","01877","BK1161"],"gpt_icon":0},{"id":"2610910016","title":"君实生物02月09日主力净流入537.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610910016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610910016?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624958,"startTime":"0","endTime":"0","summary":"02月09日, 君实生物股价涨4.71%，报收21.78元，成交金额6810.0万元，换手率1.20%，振幅4.62%，量比1.08。君实生物今日主力资金净流入537.6万元，上一交易日主力净流出108.5万元。该股近5个交易日上涨6.24%，主力资金累计净流入1861.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1340.7万元，其中净流入天数为10日。该股主力净额占比0.09%，港股市场排名94/2715。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162458a6e5407a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162458a6e5407a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1515","01877","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.1052},{"period":"3month","weight":-0.1643},{"period":"6month","weight":-0.3138},{"period":"1year","weight":0.5564},{"period":"ytd","weight":-0.0037}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0},{"period":"3month","weight":0.0316},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.067085},{"month":3,"riseRate":0.714286,"avgChangeRate":0.049127},{"month":4,"riseRate":0.857143,"avgChangeRate":0.101581},{"month":5,"riseRate":0.428571,"avgChangeRate":0.004505},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.018268},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}